Adams Named Chair of Dermatology
Brian Adams, MD, MPH, has been approved by the UC Board of Trustees as the permanent chair of the UC Department of Dermatology. He also will hold the Drs. Diya F. Mutasim & Hugh M. Gloster Jr. & Harry L. Claassen Endowed Chair of Dermatology. Adams has served as interim chair of the department since Jan. 1, 2013.
He joined the faculty of the department in 1999, after completing his internship and residency at the UC College of Medicine.
A board-certified dermatologist, he also serves as director of dermatology for the Cincinnati Department of Veterans Affairs Medical Center and leads the UC dermatology departments sports dermatology clinic and its residency program. Additionally, Dr. Adams is a member of the Athletic Training Program at the School of Human Services within UC's College of Education, Criminal Justice and Human Services.
He is the official dermatologist for the Womens Tennis Association and a member of several national committees related to sports medicine and dermatology. His ongoing research focuses on skin cancer prevention among athletes. Adams authored the 2006 book
and has authored or co-authored more than 135 manuscripts, abstracts and book chapters (including the chapter on sports dermatology for the International Olympic Committees medical textbook).
He also serves as an assistant coach for the Archbishop Moeller High School varsity cross country team.
Adams will serve from 2015 to 2019 as the chairman of the American Academy of Dermatology Sports Committee and is a member of the American College of Sports Medicines Combative Sports Interest Group.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.